Clinical Trial Detail

NCT ID NCT03926013
Title A Study of JNJ-63898081 in Participants With Advanced Stage Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Janssen Research & Development, LLC
Indications

prostate adenocarcinoma

renal cell carcinoma

Therapies

JNJ-63898081

Age Groups: senior adult

No variant requirements are available.